Skip to main content
MethodsX logoLink to MethodsX
. 2020 Nov 28;7:101165. doi: 10.1016/j.mex.2020.101165

High-performance method for identification of super enhancers from ChIP-Seq data with configurable cloud virtual machines

Natalia N Orlova a, Olga V Bogatova a, Alexey V Orlov a,b,
PMCID: PMC7897706  PMID: 33665151

Abstract

A universal method for rapid identifying super-enhancers which are large domains of multiple closely-spaced enhancers is proposed. The method applies configurable cloud virtual machines (cVMs) and the rank-ordering of super-enhancers (ROSE) algorithm. To identify super-enhancers a сVM-based analysis of the ChIP-seq binding patterns of the active enhancer-associated mark is employed. The use of the proposed method is described step-by-step: configuration of cVM; ChIP-seq data alignment; peak calling; ROSE algorithm; interpretation of the results on a client machine. The method was validated for the search of super-enhancers using the H3K27ac mark in the sample datasets of a cell line (human MCF-7), mouse tissue (heart), and human tissue (adrenal gland). The total analysis cycle time of raw ChIP-seq data ranges from 15 to 48 min, depending on the number of initial short reads. Depending on the data processing step and availability of multi-threading, a cVM can be scaled up to a multi-CPU configuration with large amount of RAM. An important feature of the method is that it can run on a client machine that has low-performance with virtually any OS. The proposed method allows for simultaneous and independent processing of different sample datasets on multiple clones of a single cVM.

  • Cloud VMs were used for rapid processing of ChIP-seq data to identify super-enhancers.

  • The method can use a low-performance computer with virtually any OS on it.

  • It can be scaled up for parallel processing of individual sample datasets on their own VMs for rapid high-throughput processing.

Keywords: Epigenomics, Chromatin immunoprecipitation followed by sequencing, Next generation sequencing, Stitched enhancers, H3K27ac

Graphical abstract

Image, graphical abstract


Specifications

Subject Area: Bioinformatics
More specific subject area: Methods for chromatin immunoprecipitation followed by sequencing (ChIP-seq) analysis
Method name: Identification of super enhancers from ChIP-seq data with configurable cloud virtual machines
Name and reference of original method: Rank Ordering Of Super-Enhancers (ROSE) algorithm [1,2]
Resource availability: https://github.com/ChIP-seq/cloudROSE

Method details

Introduction

A novel modern epigenomics approach which was introduced in 2013 but has already proven to be highly efficient, is the identification of super-enhancers – large domains of multiple closely-spaced enhancers [1], [2], [3]. These sites play an important role in the transcriptional regulation in many diseases [4], [5], [6], [7]. Super-enhancers have been demonstrated to be a promising target in the studies of cancer (acute myeloid leukemia [8], neuroblastoma [9], etc.) and a wide range of other disorders, such as type 1 diabetes [3], Alzheimer's disease [10] and multiple sclerosis [11]. However, the existing methods for identification of super-enhancers are time-consuming and resource-intensive. In this work, we propose a fast method for super-enhancer identification using a low-performance computer based on configurable cloud virtual machines (cVMs) and the Rank-Ordering of Super-Enhancers (ROSE) algorithm.

Creation of a virtual machine

Currently, there is a number of various cloud-based virtual machine services, including commercial projects such as Amazon Web Services (AWS), Microsoft Azure and Google Cloud Platform (GCP) [12], [13], [14]. In this work, we used cVMs created with Yandex Compute Cloud based on CentOS 8 with 200 GB HDD. Detailed guidelines to set up a cVM are usually released by the service that provides the virtual machine. In particular, for the cVMs used in this work these instructions are described in Ref. [15].

Importantly, one can manage a cVM using a low-performance client machine running virtually any OS. To demonstrate this feature, we performed all operations on a laptop with a single 1.9 GHz core and 2 GB RAM. The cVM configuration (number of CPUs and the amount of RAM) was set on-demand depending on the stage of the method and is described below. When creating a cVM, we chose a cost-efficient configuration with 2 CPUs and 2 GB RAM. To speed up the processing of multiple datasets, a pre-configured cVM was cloned to operate multiple instances of one cVM simultaneously and independently. This feature dramatically reduces the total processing time for large numbers of sample datasets. Notably, cVMs could be created using almost any services that support the SSH protocol to implement the proposed method.

SSH key pair generation

Depending on the client machine OS, the procedure for generating an SSH key pair is described below.

Linux/MacOS/Windows 10

To generate public/private key pairs use ssh-keygen command in a terminal/command prompt:

  • $ ssh-keygen -t rsa -b 2048

Enter the names of the files where the keys are to be saved and enter the private key password. The default file name is id_rsa, and the keys are created in the ~/.ssh directory on Linux/MacOS and in the C:\Users\<user_name>\.ssh\ on Windows 10. The public part of the key is saved in a file 〈key_name〉.pub. Paste this key into the SSH key field when creating a new cVM via the console.

Windows 7/8

SSH keys for Windows 7/8 are generated using the PuTTY SSH client [16]. Select key type as RSA and 2048 as the key size. Press Generate and keep moving your mouse over the blank area until the key is complete. Enter password in Key passphrase and click Save private key. Copy the contents of your public key from the text box to a text file and enter it when creating a cVM via the console.

Connection to a virtual machine

Start the cVM instance through the console and use for connection the SSH client on Linux/macOS/Windows 10, or PuTTY on Windows 7/8. In order to connect to a cVM, provide the public address of the cVM. Depending on the client machine OS, the procedure for connecting to a cVM is as follows:

Linux/MacOS/Windows 10

Run the following command in a terminal/command prompt:

  • $ ssh -i〈path/to/id_rsa〉 <user_name>@<cVM IP address or name>

If you are connecting to the cVM for the first time, you might get the ‘unknown host’ warning.

Windows 7/8

Use PuTTY SSH client to connect to a cVM on Windows 7/8. Start the Pageant application and select Add key in the context menu. Select the generated by PuTTY .ppk private key and enter the password. Then, launch PuTTY and enter the public IP address of the cVM in Host Name (or IP address). Enter port 22 and SSH connection type. Open Connection - SSH - Auth on the left-hand side of the tree. Check box Allow agent forwarding. In the Private key file for authentication field, select the private key file and click Open. If you are connecting to the cVM for the first time, you might get the ‘unknown host’ warning.

Installation of updates and required packages

Before data processing with a newly created cVM, install the updates and required packages:

  • $ sudo yum update

  • $ sudo yum install wget gcc unzip bzip2 tar make git

Note that yum commands is mainly used in CentOS, for Debian/Ubuntu systems use apt-get instead.

Download and quality assessment of ChIP-Seq raw data

In this work, we used the ChIP-Seq data from the Encyclopedia of DNA Elements (ENCODE) public database. The data was retrieved onto the cVM using the command wget from the ENCODE Project Portal: https://www.encodeproject.org. All the data that we used here are listed in the Method Validation section. The following test/control sample datasets were used: cell line (human MCF-7), ENCFF000VHD/ENCFF000VHL; mouse tissue (heart), ENCFF483VRP/ENCFF183PVA; and human tissue (adrenal gland), ENCFF697BQR/ENCFF225QVL.

The ChIP-seq raw data is analyzed on a client machine using FastQC quality control tool [17].

Alignment with bowtie2

The first step in processing ChIP-seq raw data is to align them with a reference genome. For this purpose, we used bowtie2 tool for aligning sequencing reads [18] which we installed using bioconda package [19] preinstalled on the cVM:

Set the path to conda with the command:

  • $ export PATH=$PATH:/path/to/conda/bin

Then, we installed bowtie2:

  • $ conda install -c bioconda bowtie2

To use bowtie2, one first needs the index of the reference genome for the corresponding ChIP-seq data. To index a genome, one can use a built-in command bowtie2-build [20], or can download pre-indexed genomes at http://bowtie-bio.sourceforge.net/bowtie2. We worked with Mus musculus (house mouse) genome (mm10) and Homo sapiens (human) genome GRCh38, the indices of which were obtained with the commands:

Genome alignment is relatively time-consuming and resource-intensive. Therefore, before starting the analysis, we reconfigured the сVM in order to speed up the alignment via multi-threading. In particular, we increased the number of CPUs to 64 and the amount of RAM to 256 GB. Then, we started the alignment with the following command:

  • $ bowtie2 -p 64 -q –local -x〈bt2-index〉 −1〈path to File 1〉 −2〈path to File 2〉 -S〈path to output file〉

Here, 〈bt2-index〉 is the basename of the index for the reference genome; 〈path to File 1〉 is the path to the paired-end FASTQ File 1; 〈path to File 2〉 is the path to the paired-end FASTQ File 2. If the data were unpaired and contained in a single file, then instead of ‘−1 〈path to File 1〉 −2 <path to File 2>’, use “–U <path to File>”. As a result, a SAM file is received that was subsequently converted and sorted using samtools [21].

Conversion and sorting using samtools

Samtools were installed on cVM using bioconda:

  • $ conda install -c bioconda samtools

Note that samtools depends on library libncurses.so.5. Therefore, if ncurses6.2 is installed than create a symbolic link for libncurses.so.5 to libncurses.so.6:

  • $ ln -s ~/miniconda3/lib/libncurses.so.6.2 ~/miniconda3/lib/libncurses.so.5

The SAM file obtained by bowtie2, we converted to a BAM file:

  • $ samtools view -S -b - @ 64〈path to SAM File〉 〈path to BAM File〉

Then, we sorted the BAM file:

  • $ samtools sort -o - @ 64〈path to sorted BAM File〉 〈path to BAM File〉

Based on the sorted BAM file, one can generate an index file for fast random access using the command below:

  • $ samtools index〈path to sorted BAM File〉

Peak calling with Macs2

Peak calling was performed using the MACS algorithm (Model-Based Analysis of ChIP-Seq) [22], [23], [24] in MACS2 2.2.7.1 [25]. We installed MACS2 as follows:

To run MACS2, one need to process two ChIP-seq data sets as described above and get two sorted BAM files — for a test sample and for a control sample. Then, run MACS2 as follows:

  • $ macs2 callpeak -p 1e-9 –keep-dup=auto -t〈path to the BAM-sorted test sample file〉 -c〈path to the BAM-sorted control sample file〉 -n〈output path〉

Identification of super-enhancers with ROSE

To find and identify super-enhancers, we used the Rank Ordering of Super-Enhancers (ROSE) algorithm [1,2]. It requires Python 2.7 which was pre-installed as follows:

ROSE-package was cloned from the Barsky lab:

To start ROSE, use the command:

  • python2.7 〈ROSE path〉 /ROSE_main.py -g 〈genome build: one of hg18, hg19, mm8, mm9, or mm10〉 -i 〈peaks.bed path created by MACS2〉 -r 〈path to BAM-sorted test sample file〉 -c 〈path to the BAM-sorted control sample file〉 -o 〈output path〉 -s 12,500 -t 2000

Processing of results

After processing the data in the cVM, we transferred the files with the results to the client machine using FileZilla and processed them with standard tools such as IGV Browser, Excel, etc. All output files obtained as a result of the ROSE algorithm are available on the resource: https://github.com/ChIP-seq/cloudROSE.

Method validation

To demonstrate the capabilities of the method, we performed a search for super-enhancers in three different sample types – a cell line (human MCF-7), a mouse tissue (heart), and a human tissue (adrenal gland). The acetylation at the 27th lysine residue of the histone H3 protein (H3K27Ac) was used as an enhancer mark. Table 1 provides information on the ChIP-seq data from the ENCODE Project that we used.

Table 1.

Information about ChIP-seq data used.

Dataset ID Sample Type ChIP-seq Mark Platform Reference Genome
ENCFF000VHD Cell line
(human MCF-7)
H3K27Ac Illumina Genome Analyzer GRCh38
ENCFF000VHL Cell line
(human MCF-7)
Control
(input library)
Illumina Genome Analyzer GRCh38
ENCFF483VRP Mouse tissue
(heart)
H3K27Ac Illumina
HiSeq 4000
Mm10
ENCFF183PVA Mouse tissue
(heart)
Control
(input library)
Illumina
HiSeq 4000
Mm10
ENCFF697BQR Human tissue
(adrenal gland)
H3K27Ac Illumina HiSeq 2500 GRCh38
ENCFF225QVL Human tissue
(adrenal gland)
Control
(input library)
Illumina HiSeq 2500 GRCh38

Table 2 shows the cVM configurations at each step of data processing using the developed method. cVM configuration was chosen in order to optimize the processing time, taking into account the possibility of multi-threading at a particular stage. We increased the number of CPUs and the amount of RAM as long as it still resulted in shorter processing times.

Table 2.

Cloud VM configurations at each step of data processing using the developed method.

Alignment
(bowtie2)
Conversion (samtools) Sorting (samtools) Peak Calling
(MACS2)
Identified Super-Enhancers (ROSE)
CPU 64 8 8 8 4
RAM 256 16 16 16 8

Table 3 shows method operating time at each of the processing steps and the number of potential super enhancer. Fig. 1 shows the results of ROSE for each of three sample types – cell line (human MCF-7), mouse tissue (heart), and human tissue (adrenal gland). The full processing time of raw ChIP-seq raw data ranged from 14 min 37 s to 48 min 03 s for a test/control pair of sample datasets depending on the number of the initial short reads. As one can see from the table, the processing time at each step was almost linear to the number of the short reads in the ChIP-seq raw data.

Table 3.

The processing time of the method at each data processing step and the number of identified super-enhancers.

Sample Type Test/
Control
Number of Reads Processing time
Potential super-enhancers
Alignment
(bowtie2)
Conversion (samtools) Sorting
(samtools)
Peak calling (MACS2) Identification of super-enhancers (ROSE) Total
Cell line (human MCF-7) Test 31,418,572 02 m 42s 00 m 43s 00 m 37s 03 m 42s 05 m 30s 14 m 37s 72
Control 18,714,964 00 m 44s 00 m 23s 00 m 16s
Mouse tissue (heart) Test 36,752,873 03 m 48s 00 m 57s 00 m 50s 11 m 09s 20 m 32s 48 m 03s 338
Control 85,608,717 06 m 53s 02 m 17s 01 m 37s
Human tissue (adrenal gland) Test 33,443,289 04 m 12s 01 m 06s 00 m 56s 06 m 43s 10 m 27s 30 m 23s 123
Control 41,510,868 04 m 45s 01 m 20s 00 m 54s

Fig. 1.

Fig 1

Dependence of normalized signal on the peak rank: the ChIP-Seq data ROSE processing results using the H3K27Ac enhancer mark in (a) MCF-7 human cell line; (b) mouse heart; and (c) human adrenal gland.

It should be noted that the stage of alignment reads is traditionally one of the most time-consuming steps in many genomics pipelines. With the developed method, it took a relatively short period of time – from 44 s for the sample dataset of 18.7 million reads to 6 min 53 s for the sample dataset of 85.6 million reads. This is primarily due to the efficient multi-threading algorithms underlying the bowtie2 tools which were implemented on a cVM with 64 CPUs.

At the same time, as can be seen from Table 3, the ROSE algorithm turned out to be the slowest, most likely due to the fact that it is least efficient with multi-threading. Growing each cVM performance by increasing the number of CPUs or RAM amount did not significantly accelerate the ROSE. Nevertheless, the proposed method allows for simultaneous and independent processing of different sample datasets on different cVMs. To achieve this, the configured cVM is cloned in the required number of instances, and an individual cVM clone processes one dataset of test/control pair.

In our case, we ran ROSE algorithm simultaneously for all sample datasets on several low-performance cVMs instances. Here, the total processing time of all samples was actually equal to the processing time of one (the slowest) sample dataset. Parallel and independent processing of individual sample datasets on their own cVMs is one of the significant advantages of the proposed method that can be used for rapid high-throughput processing. Besides, due to the universal concept of a cloud virtual machine, the proposed method can be scaled up to address other resource-intensive biocomputing applications for analysis of genome-wide sequencing data. The method can be also used for the optimization of the ChIP-seq assay and for developing multiplex biosensing systems that provide highly sensitive detection of the agents essential in medical diagnostics [[26], [27]], veterinary medicine, food quality control [[28], [29]], environmental monitoring [30] and other applications.

Declaration of Competing Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Acknowledgements

The research was supported by Russian Foundation for Basic Research (grant 19-34-80052) and by a grant of the Ministry of Science and Higher Education of the Russian Federation for large scientific projects in priority areas of scientific and technological development (Registration number 2020-1902-01-222, subsidy identifier 075-15-2020-774).

References

  • 1.Whyte W.A., Orlando D.A., Hnisz D., Abraham B.J., Lin C.Y., Kagey M.H., Rahl P.B., Lee T.I., Young R.A. Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell. 2013;153:307–319. doi: 10.1016/j.cell.2013.03.035. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Lovén J., Hoke H.A., Lin C.Y., Lau A., Orlando D.A., Vakoc C.R., Bradner J.E., Lee T.I., Young R.A. Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell. 2013;153:320–334. doi: 10.1016/j.cell.2013.03.036. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Hnisz D., Abraham B.J., Lee T.I., Lau A., Saint-André V., Sigova A.A., Hoke H.A., Young R.A. Super-enhancers in the control of cell identity and disease. Cell. 2013;155:934–947. doi: 10.1016/j.cell.2013.09.053. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Wang X., Cairns M.J., Yan J. Super-enhancers in transcriptional regulation and genome organization. Nucl. Acids Res. 2019;47:11481–11496. doi: 10.1093/nar/gkz1038. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Thandapani P. Super-enhancers in cancer. Pharmacol. Ther. 2019;199:129–138. doi: 10.1016/j.pharmthera.2019.02.014. [DOI] [PubMed] [Google Scholar]
  • 6.Jia Y., Chng W.-.J., Zhou J. Super-enhancers: critical roles and therapeutic targets in hematologic malignancies. J. Hematol. Oncol. 2019;12:77. doi: 10.1186/s13045-019-0757-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Khan A., Mathelier A., Zhang X. Super-enhancers are transcriptionally more active and cell type-specific than stretch enhancers. Epigenetics. 2018;13:910–922. doi: 10.1080/15592294.2018.1514231. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Wouters B.J., Delwel R. Epigenetics and approaches to targeted epigenetic therapy in acute myeloid leukemia. Blood. 2016;127:42–52. doi: 10.1182/blood-2015-07-604512. [DOI] [PubMed] [Google Scholar]
  • 9.Oldridge D.A., Wood A.C., Weichert-Leahey N., Crimmins I., Sussman R., Winter C., McDaniel L.D., Diamond M., Hart L.S., Zhu S., Durbin A.D., Abraham B.J., Anders L., Tian L., Zhang S., Wei J.S., Khan J., Bramlett K., Rahman N., Capasso M., Iolascon A., Gerhard D.S., Guidry Auvil J.M., Young R.A., Hakonarson H., Diskin S.J., Thomas Look A., Maris J.M. Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism. Nature. 2015;528:418–421. doi: 10.1038/nature15540. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Parker S.C.J., Stitzel M.L., Taylor D.L., Orozco J.M., Erdos M.R., Akiyama J.A., Van Bueren K.L., Chines P.S., Narisu N., Black B.L., Axel V., Pennacchio L.A., Collins F.S. Chromatin stretch enhancer states drive cell-specific gene regulation and harbor human disease risk variants. Proc. Natl. Acad. Sci. USA. 2013;110:17921–17926. doi: 10.1073/pnas.1317023110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Vahedi G., Kanno Y., Furumoto Y., Jiang K., Parker S.C.J., Erdos M.R., Davis S.R., Roychoudhuri R., Restifo N.P., Gadina M., Tang Z., Ruan Y., Collins F.S., Sartorelli V., O'Shea J.J. Super-enhancers delineate disease-associated regulatory nodes in T cells. Nature. 2015;520:558–562. doi: 10.1038/nature14154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Grossman R.L., Lakes Data. Clouds, and commons: a review of platforms for analyzing and sharing genomic data. Trends Genet. 2019;35:223–234. doi: 10.1016/j.tig.2018.12.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Kasson P.M. Vol. 2013. World Scientific; 2013. Computational biology in the cloud: methods and new insights from computing at scale; pp. 451–453. (Biocomput). [PubMed] [Google Scholar]
  • 14.Chandrasekaran K. CRC Press; 2014. Essentials of Cloud Computing. [DOI] [Google Scholar]
  • 15.https://cloud.yandex.com/docs/compute/operations/vm-create/create-linux-vm, (2020).
  • 16.J. Tatham, S., Dunn, O., Harris, B., Nevins, PuTTY: a free Telnet/SSH client, (2006). https://www.putty.org/.
  • 17.Andrews S. FASTQC a quality control tool for high throughput sequence data. Babraham Inst. 2015 https://www.bioinformatics.babraham.ac.uk/projects/fastqc/ [Google Scholar]
  • 18.Langmead B., Salzberg S.L. Fast gapped-read alignment with Bowtie 2. Nat. Methods. 2012;9:357. doi: 10.1038/nmeth.1923. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Grüning B., Dale R., Sjödin A., Chapman B.A., Rowe J., Tomkins-Tinch C.H., Valieris R., Köster J. Bioconda: sustainable and comprehensive software distribution for the life sciences. Nat. Methods. 2018;15:475–476. doi: 10.1038/s41592-018-0046-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Bowtie 2: Manual, (2020). http://bowtie-bio.sourceforge.net/bowtie2/manual.shtml.
  • 21.Li H., Handsaker B., Wysoker A., Fennell T., Ruan J., Homer N., Marth G., Abecasis G., Durbin R. The sequence alignment/map format and SAMtools. Bioinformatics. 2009;25:2078–2079. doi: 10.1093/bioinformatics/btp352. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Zhang Y., Liu T., Meyer C.A., Eeckhoute J., Johnson D.S., Bernstein B.E., Nussbaum C., Myers R.M., Brown M., Li W., Shirley X.S. Model-based analysis of ChIP-Seq (MACS) Genome Biol. 2008;19:1–9. doi: 10.1186/gb-2008-9-9-r137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Feng J., Liu T., Qin B., Zhang Y., Liu X.S. Identifying ChIP-seq enrichment using MACS. Nat. Protoc. 2012;7:1728–1740. doi: 10.1038/nprot.2012.101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Feng J., Liu T., Zhang Y. Using MACS to identify peaks from ChIP-seq data. Curr. Protoc. Bioinforma. 2011;34:2–14. doi: 10.1002/0471250953.bi0214s34. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.MACS2, (2020). https://pypi.org/project/MACS2/.
  • 26.Orlov A.V., Pushkarev A.V., Znoyko S.L., Novichikhin D.O., Bragina V.A., Gorshkov B.G., Nikitin P.I. Multiplex label-free biosensor for detection of autoantibodies in human serum: tool for new kinetics-based diagnostics of autoimmune diseases. Biosensors and Bioelectronics. 2020;159:112187. doi: 10.1016/j.bios.2020.112187. [DOI] [PubMed] [Google Scholar]
  • 27.Orlov A.V., Burenin A.G., Shipunova V.O., Lizunova A.A., Gorshkov B.G., Nikitin P.I. Development of immunoassays using interferometric real-time registration of their kinetics. Acta Naturae. 2014;6:85–95. doi: 10.32607/20758251-2014-6-1-85-95. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Ivanov A.E., Pushkarev A.V., Orlov A.V., Nikitin M.P., Nikitin P.I. Interferometric detection of chloramphenicol via its immunochemical recognition at polymer-coated nano-corrugated surfaces. Sensors and Actuators B: Chemical. 2019;282:984–991. doi: 10.1016/j.snb.2018.11.043. [DOI] [Google Scholar]
  • 29.Orlov A.V., Pushkarev A.V., Mochalova E.N., Nikitin P.I., Nikitin M.P. Development and label-free investigation of logic-gating biolayers for smart biosensing. Sensors and Actuators B: Chemical. 2018;257:971–979. doi: 10.1016/j.snb.2017.11.025. [DOI] [Google Scholar]
  • 30.Burenin A.G., Nikitin M.P., Orlov A.V., Ksenevich T.I., Nikitin P.I. Detection of pyrethroids by spectral correlation interferometry. Applied Biochemistry and Microbiology. 2013;49:306–311. doi: 10.1134/S0003683813030058. [DOI] [PubMed] [Google Scholar]

Articles from MethodsX are provided here courtesy of Elsevier

RESOURCES